Companies / South Korea
Pfizer Planning To Close South Korean Facility
April 2006 | Company Finance AlertUS drugmaker Pfizer has become the latest multinational drug firm to close a manufacturing plant South Korea after ceasing operations at its facility in Seoul. The factory produces hypertension drug Norvasc, which accounted for approximately one-third of all of Pfizer Korea's revenue last year.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
